Loading...

Augmented Interferon-α Pathway Activation in Patients With Sjögren's Syndrome Treated With Etanercept

OBJECTIVE: Recent clinical trials suggest that etanercept is ineffective in controlling Sjögren's syndrome (SS). To address the hypothesis that tumor necrosis factor blockade can result in increased levels of interferon-α (IFNα) and BAFF, we quantified those mediators in plasma from etanercept-...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Mavragani, Clio P., Niewold, Timothy B., Moutsopoulos, Niki M., Pillemer, Stanley R., Wahl, Sharon M., Crow, Mary K.
Format: Artigo
Sprog:Inglês
Udgivet: 2007
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2737264/
https://ncbi.nlm.nih.gov/pubmed/18050196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.23062
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!